Annual Total Expenses
$17.44 M
-$406.00 K-2.28%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual total expenses is $17.44 million, with the most recent change of -$406.00 thousand (-2.28%) on March 31, 2024.
- During the last 3 years, SNOA annual total expenses has fallen by -$4.64 million (-21.03%).
- SNOA annual total expenses is now -43.48% below its all-time high of $30.85 million, reached on March 31, 2018.
Performance
SNOA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$4.59 M
+$166.00 K+3.75%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly total expenses is $4.59 million, with the most recent change of +$166.00 thousand (+3.75%) on December 31, 2024.
- Over the past year, SNOA quarterly total expenses has increased by +$613.00 thousand (+15.39%).
- SNOA quarterly total expenses is now -45.32% below its all-time high of $8.40 million, reached on March 31, 2018.
Performance
SNOA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
SNOA Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.3% | +15.4% |
3 y3 years | -21.0% | +10.4% |
5 y5 years | -42.3% | +10.4% |
SNOA Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -21.0% | at low | -14.2% | +19.0% |
5 y | 5-year | -42.3% | at low | -39.0% | +19.0% |
alltime | all time | -43.5% | +712.1% | -45.3% | +221.0% |
Sonoma Pharmaceuticals Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | $4.59 M(+3.7%) |
Sep 2024 | - | $4.43 M(-3.0%) |
Jun 2024 | - | $4.56 M(-5.9%) |
Mar 2024 | $17.44 M(-2.3%) | $4.85 M(+21.7%) |
Dec 2023 | - | $3.98 M(+1.1%) |
Sep 2023 | - | $3.94 M(-15.6%) |
Jun 2023 | - | $4.67 M(+12.2%) |
Mar 2023 | $17.84 M(-3.6%) | $4.16 M(-12.9%) |
Dec 2022 | - | $4.78 M(+17.6%) |
Sep 2022 | - | $4.06 M(-16.0%) |
Jun 2022 | - | $4.84 M(-9.7%) |
Mar 2022 | $18.52 M(-16.1%) | $5.36 M(+38.8%) |
Dec 2021 | - | $3.86 M(-18.0%) |
Sep 2021 | - | $4.71 M(+2.6%) |
Jun 2021 | - | $4.59 M(-7.7%) |
Mar 2021 | $22.08 M(-12.8%) | $4.97 M(-2.0%) |
Dec 2020 | - | $5.07 M(-9.4%) |
Sep 2020 | - | $5.60 M(-12.9%) |
Jun 2020 | - | $6.43 M(-14.6%) |
Mar 2020 | $25.32 M(-16.2%) | $7.54 M(+36.9%) |
Dec 2019 | - | $5.50 M(-8.5%) |
Sep 2019 | - | $6.01 M(-4.0%) |
Jun 2019 | - | $6.27 M(-11.6%) |
Mar 2019 | $30.23 M(-2.0%) | $7.09 M(-7.1%) |
Dec 2018 | - | $7.63 M(+0.5%) |
Sep 2018 | - | $7.59 M(-4.2%) |
Jun 2018 | - | $7.92 M(-5.7%) |
Mar 2018 | $30.85 M(+19.6%) | $8.40 M(+4.5%) |
Dec 2017 | - | $8.04 M(+12.0%) |
Sep 2017 | - | $7.18 M(-0.5%) |
Jun 2017 | - | $7.22 M(+4.0%) |
Mar 2017 | $25.80 M(+7.1%) | $6.94 M(+0.2%) |
Dec 2016 | - | $6.93 M(+19.7%) |
Sep 2016 | - | $5.78 M(-5.9%) |
Jun 2016 | - | $6.15 M(-0.7%) |
Mar 2016 | $24.08 M(+17.4%) | $6.19 M(-7.2%) |
Dec 2015 | - | $6.67 M(+12.9%) |
Sep 2015 | - | $5.91 M(-1.3%) |
Jun 2015 | - | $5.99 M(+6.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2015 | $20.51 M(+4.0%) | $5.63 M(+9.0%) |
Dec 2014 | - | $5.17 M(+7.5%) |
Sep 2014 | - | $4.81 M(-2.0%) |
Jun 2014 | - | $4.91 M(-2.3%) |
Mar 2014 | $19.72 M(+4.7%) | $5.02 M(+3.8%) |
Dec 2013 | - | $4.84 M(-9.7%) |
Sep 2013 | - | $5.36 M(+19.2%) |
Jun 2013 | - | $4.50 M(-4.6%) |
Mar 2013 | $18.83 M(-2.0%) | $4.72 M(+11.8%) |
Dec 2012 | - | $4.22 M(-21.0%) |
Sep 2012 | - | $5.34 M(+17.5%) |
Jun 2012 | - | $4.55 M(-5.6%) |
Mar 2012 | $19.21 M(+11.3%) | $4.82 M(-6.4%) |
Dec 2011 | - | $5.14 M(+19.8%) |
Sep 2011 | - | $4.29 M(-13.4%) |
Jun 2011 | - | $4.96 M(+21.0%) |
Mar 2011 | $17.26 M(+12.2%) | $4.10 M(-6.7%) |
Dec 2010 | - | $4.39 M(+6.8%) |
Sep 2010 | - | $4.11 M(-11.8%) |
Jun 2010 | - | $4.66 M(+26.4%) |
Mar 2010 | $15.38 M(-32.2%) | $3.69 M(+1.9%) |
Dec 2009 | - | $3.62 M(-7.9%) |
Sep 2009 | - | $3.93 M(-5.3%) |
Jun 2009 | - | $4.15 M(+11.4%) |
Mar 2009 | $22.70 M(-13.6%) | $3.72 M(-14.6%) |
Dec 2008 | - | $4.36 M(-46.2%) |
Sep 2008 | - | $8.11 M(+29.0%) |
Jun 2008 | - | $6.29 M(-6.2%) |
Mar 2008 | $26.26 M(+9.3%) | $6.70 M(+1.2%) |
Dec 2007 | - | $6.62 M(-0.5%) |
Sep 2007 | - | $6.66 M(+6.0%) |
Jun 2007 | - | $6.28 M(-9.4%) |
Mar 2007 | $24.03 M(+2.5%) | $6.93 M(+12.4%) |
Dec 2006 | - | $6.17 M(-262.5%) |
Sep 2006 | - | -$3.80 M |
Mar 2006 | $23.43 M(+32.6%) | - |
Mar 2005 | $17.67 M(+348.7%) | - |
Mar 2003 | $3.94 M(+83.4%) | - |
Mar 2002 | $2.15 M | - |
FAQ
- What is Sonoma Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual total expenses year-on-year change?
- What is Sonoma Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly total expenses year-on-year change?
What is Sonoma Pharmaceuticals annual total expenses?
The current annual total expenses of SNOA is $17.44 M
What is the all time high annual total expenses for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual total expenses is $30.85 M
What is Sonoma Pharmaceuticals annual total expenses year-on-year change?
Over the past year, SNOA annual total expenses has changed by -$406.00 K (-2.28%)
What is Sonoma Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of SNOA is $4.59 M
What is the all time high quarterly total expenses for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly total expenses is $8.40 M
What is Sonoma Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, SNOA quarterly total expenses has changed by +$613.00 K (+15.39%)